Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase RegistryAnnamaria Brioli, Michael Lauseker, Fausto Castagnetti et al.|Leukemia|2024Cited by 25
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomesMaría Agustina Perusini, Dennis Dong Hwan Kim, Daniela Žáčková et al.|Blood Advances|2024Cited by 14
Treatment and outcome of 2904 CML patients from the EUTOSpopulation-based registryVerena Hoffmann, R. Hehlmann, Michele Baccarani et al.|Leukemia|2017Cited by 0
Somatic mutations in myeloid transcription factors and in activated signaling genes predict the risk of treatment failure and progression to advanced phase in chronic myeloid leukemiaDennis Dong Huan Kim, Jiří Mayer, María Agustina Perusini et al.|Research Square|2023Cited by 0
Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free RemissionMaría Agustina Perusini, Dennis Dong Hwan Kim, Kátia Bórgia Barbosa Pagnano et al.|Blood|2023Cited by 0